Summary: While psilocybin is hailed as a breakthrough for depression and anxiety, many patients remain wary of the intense “trips” associated with the drug. Now, researchers have engineered modified versions…
Category: psychopharmacology
Psychedelics Remodel Myelin to Heal PTSD
Summary: For years, scientists have focused on how psychedelics “rewire” neurons. But a groundbreaking study has found a “missing link” in long-term PTSD recovery: myelin remodeling. Researchers discovered that psilocybin…
Moving Beyond Dopamine to Treat Schizophrenia
Summary: Schizophrenia treatment has been dominated by dopamine-targeting drugs for decades, but these often fail to address the debilitating cognitive and negative symptoms of the disorder. A comprehensive review synthesizes…
Single DMT Dose Provides Lasting Relief from Depression
Summary: While psychedelic research often focuses on hours-long “trips” with psilocybin or LSD, a landmark Phase IIa trial has proven that a much shorter experience can be just as potent.…
Anti-Inflammatory Treatments Show Promise for Depression
Summary: A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who also have chronic, low-grade inflammation. By reviewing randomized controlled trials…
Psychedelic ‘Ego Death’ Tied to a Collapse in Alpha Brain Waves
Summary: A new study using DMT as a scientific tool reveals how psychedelics alter the brain’s alpha-wave dynamics and weaken our sense of self. The researchers found that DMT pushes…
New Drug Exposes Hidden Subtypes of Psychosis
Summary: A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the first new schizophrenia drug mechanism approved in 50 years.…
Antibiotic Doxycycline May Cut Schizophrenia Risk
Summary: A large population-based study suggests that doxycycline, a common antibiotic, may reduce the risk of schizophrenia when prescribed to adolescents receiving mental health care. Researchers analyzed data from more…
Common Antidepressant Eases Core Symptoms Within Two Weeks
Summary: A new analysis of the PANDA clinical trial reveals that sertraline, one of the most prescribed antidepressants, improves key emotional symptoms of depression—such as sadness, self-loathing, and suicidal thoughts—within…
EEG Test May Reveal Who Loses Libido on Antidepressants
Summary: A new study reveals that serotonin levels in the brain, measured using a simple EEG-based test, can predict who will experience sexual side effects from SSRI antidepressants. Researchers found…
